Pharmaceutical Technology: News, Analysis & Industry Insights

News

Astellas fortifies immuno-oncology pipeline on $1.3bn Audax licensing deal

Astellas pens this deal as it looks to offset the upcoming patent expiry of key portfolio medicine, Xtandi.

Annabel Kartal Allen

News

Ferring bets on Gameto’s reproductive health solution through $1.38bn takeover

Annabel Kartal Allen

News

Anthropic plots IPO amid ongoing foray into drug development

Annabel Kartal Allen

PremiumAnalyst Comment

ESMO26: Intismeran sets new benchmark in adjuvant melanoma

News

Arrowhead gains UK marketing authorisation for Redemplo

PremiumAnalyst Comment

ESMO26: KEYNOTE-C93 backs chemo-free Keytruda in dMMR endometrial cancer

PremiumAnalyst Comment

ESMO26: Sac-TMT sets survival benchmark in recurrent endometrial cancer

PremiumAnalyst Comment

ESMO26: SANOVO data backs 1L Orpathys use in NSCLC subgroup, but AEs temper reaction

Analysis

PremiumAnalyst Comment

IDWeek 2026: despite missing primary endpoint, LB6V shows promise in Lyme disease

GlobalData Healthcare

PremiumAnalyst Comment

ESMO26: Standard dosing prevails over 12-week checkpoint inhibitors in MOIO trial

GlobalData Healthcare

PremiumAnalyst Comment

ESMO26: Bayer’s Phase III Nubeqa win leaves survival and abiraterone questions open

GlobalData Healthcare

PremiumAnalyst Comment

ESMO26: GSK’s Mo-Rez seeks an edge in a crowded ADC field in ovarian cancer

GlobalData Healthcare

Themes

Partner Content

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

Surging demand for injectable therapies (led by GLP‑1s) is exposing a new constraint in drug delivery: not innovation, but the ability to industrialise and manufacture devices at scale.

More themes

News

Australia starts investigation into OpenAI Medicare breach

Partner Content

How DFE Pharma supports confident continuous manufacturing decisions

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Ferring bets on Gameto’s reproductive health solution through $1.38bn takeover

Anthropic plots IPO amid ongoing foray into drug development

ESMO26: Intismeran sets new benchmark in adjuvant melanoma

Arrowhead gains UK marketing authorisation for Redemplo

ESMO26: KEYNOTE-C93 backs chemo-free Keytruda in dMMR endometrial cancer

ESMO26: Sac-TMT sets survival benchmark in recurrent endometrial cancer

ESMO26: SANOVO data backs 1L Orpathys use in NSCLC subgroup, but AEs temper reaction

IDWeek 2026: despite missing primary endpoint, LB6V shows promise in Lyme disease

ESMO26: Standard dosing prevails over 12-week checkpoint inhibitors in MOIO trial

ESMO26: Bayer’s Phase III Nubeqa win leaves survival and abiraterone questions open

ESMO26: GSK’s Mo-Rez seeks an edge in a crowded ADC field in ovarian cancer

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Bio/Pharmaceutical Outsourcing Report, September 2026

IDWeek 2026: Pre-Conference Coverage

Gonorrhea: Market View, Current and Future Competitive Landscape

Ulcerative Colitis (UC): Epidemiology Report and Forecast to 2035

Venture Capital Investment Trends in Pharma - Q3 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Bio/Pharmaceutical Outsourcing Report, September 2026

IDWeek 2026: Pre-Conference Coverage

Gonorrhea: Market View, Current and Future Competitive Landscape

Ulcerative Colitis (UC): Epidemiology Report and Forecast to 2035

Venture Capital Investment Trends in Pharma - Q3 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing